|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
Monopar Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
Morphic Therapeutic, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
NeuroMetrix, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
Ventyx Biosciences, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
Sharecare, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
Tilray Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
C4 Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
Agios Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
Minerva Neurosciences Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
ProMIS Neurosciences, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
SpringWorks Therapeutics Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
Chimerix, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
Kymera Therapeutics Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
Rhythm Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
Rhythm Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
InflaRx N.V. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
Intellia Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Feb 2024
|
Related companies:
Verrica Pharmaceuticals Inc. |
|